ADVISORS LLC ORBIMED, a 10% owner of $ACET, sold 29,319 shares of the company on 04-07-2026 for an estimated $191,453. We received data on the trade from a recent SEC filing. This was a sale of approximately 45.6% of their shares of this class of stock. Following this trade, they now own 34,923 shares of this class of $ACET stock.
$ACET Insider Trading Activity
$ACET insiders have traded $ACET stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ACET stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED has made 0 purchases and 4 sales selling 104,658 shares for an estimated $674,847.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACET Hedge Fund Activity
We have seen 28 institutional investors add shares of $ACET stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 626,571 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,275,727
- WOODLINE PARTNERS LP added 625,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,262,500
- TANG CAPITAL MANAGEMENT LLC removed 507,818 shares (-98.8%) from their portfolio in Q4 2025, for an estimated $4,275,827
- RA CAPITAL MANAGEMENT, L.P. added 476,936 shares (+101.2%) to their portfolio in Q4 2025, for an estimated $4,015,801
- ORBIMED ADVISORS LLC added 312,498 shares (+43.7%) to their portfolio in Q4 2025, for an estimated $2,631,233
- PROSIGHT MANAGEMENT, LP added 250,244 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,107,054
- STONEPINE CAPITAL MANAGEMENT, LLC added 220,011 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,852,492
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACET Analyst Ratings
Wall Street analysts have issued reports on $ACET in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 01/06/2026
- HC Wainwright & Co. issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for $ACET, check out Quiver Quantitative's $ACET forecast page.
$ACET Price Targets
Multiple analysts have issued price targets for $ACET recently. We have seen 3 analysts offer price targets for $ACET in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $27.0 on 03/23/2026
- Yatin Suneja from Guggenheim set a target price of $100.0 on 03/13/2026
- John Newman from Canaccord Genuity set a target price of $18.0 on 01/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
